La description
Generic name: PEMBROLIZUMAB
Full name: KEYTRUDA **0MG/4ML CONC FOR SOL FOR INF VIAL (1) â–¼
Manufacturer:Â MERCK SHARP & DOHME LTD
Storage: FridgeÂ
Temperature: **8 degreesÂ
KEYTRUDA is indicated for the adjuvant treatment of adult and
pediatric (*2 years and older) patients with stage IIB, IIC, or III
melanoma following complete resection.
Pembrolizumab (brand name: Keytruda) is a prescription
immunotherapy drug used to treat many different types of cancer in
adults and children. Adult uses include:
melanoma, squamous cell carcinoma, or Merkel cell carcinoma (types
of serious skin cancer)
lung cancer, Non-Small Cell Lung Cancer (NSCLC)
head and neck squamous cell cancer
classical Hodgkin lymphoma (type of blood cancer))
primary mediastinal large B-cell lymphoma
cancer of the kidney, bladder, and urinary tract
liver cancer
biliary tract cancer
colorectal (colon) cancer
cancer of the cervix
endometrial cancer
advanced stomach cancer
esophageal cancer
triple negative breast cancer
Microsatellite Instability-High or Mismatch Repair Deficient Cancer
(cancer that affects the proper repair of DNA inside the cell)
Tumor Mutational Burden-High (TMB-H) Cancer (cancers that have many
gene mutations)
cancers that laboratory testing proves to have certain specific DNA
mutations
| Pays: |
UAE |
| N ° de modèle: |
-
|
| Prix FOB: |
2800 / Piece (Negotiable)
Obtenir le dernier prix
|
| Localité: |
UK |
| Prix de commande minimale: |
2800 per Piece |
| Commande minimale: |
100 Piece |
| Packaging Detail: |
- |
| Heure de livraison: |
1-4 weeks depending on location |
| Capacité de Fournir: |
500 Piece per Month |
| Payment Type: |
T/T |
| Groupe de produits : |
- |
